{{Rsnum
|rsid=10987883
|Gene=LOC100289019
|Chromosome=9
|position=128118550
|Orientation=plus
|GMAF=0.1758
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RP11-395P17.3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 72.3 | 27.7 | 0.0
| HCB | 77.8 | 20.0 | 2.2
| JPT | 68.2 | 31.8 | 0.0
| YRI | 31.7 | 55.6 | 12.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 77.8 | 20.0 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19371221
|Title=Association analysis between the prostaglandin E synthase 2 R298H polymorphism and body mass index in 8079 participants of the KORA study cohort
}}

{{PMID Auto
|PMID=21308720
|Title=Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk
}}

{{PMID|17566096}} Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}